Transient Vision Loss - A Rare Oxaliplatin-Induced Ophthalmologic Side Effect: A Report of Two Cases

Case Rep Oncol. 2021 Mar 18;14(1):483-486. doi: 10.1159/000514656. eCollection 2021 Jan-Apr.

Abstract

Oxaliplatin, a platinum-based chemotherapeutic agent, is responsible for induced peripheral sensory neuropathy. Only a few cases of ophthalmologic toxicity have been reported. We report here two cases of sudden transient vision loss after oxaliplatin administration, in one case intraperitoneally. These symptoms likely reflect optic neuritis that could be included in the spectrum of oxaliplatin-induced neuropathy.

Keywords: Acute ocular toxicity; Optic neuritis; Oxaliplatin; Sight loss.

Publication types

  • Case Reports